PE/TR Anti-Human CD49d Antibody[9F10]

Introducing the PE/TR Anti-Human CD49D Antibody [9F10], a highly advanced and meticulously crafted product designed to revolutionize the field of immunology. This antibody, with the product code E-AB-F1144P-100Tests, offers unparalleled precision and accuracy in detecting CD49D, a crucial cell surface marker associated with various physiological and pathological processes.

With its cutting-edge technology and superior quality, this antibody guarantees exceptional performance in a wide range of applications, including flow cytometry, immunofluorescence, and immunohistochemistry. Its unique formulation ensures optimal sensitivity and specificity, enabling researchers to obtain reliable and reproducible results with utmost confidence.

The PE/TR Anti-Human CD49D Antibody [9F10] is meticulously manufactured using state-of-the-art techniques and undergoes rigorous quality control measures to ensure batch-to-batch consistency and reliability. Each vial contains 100 tests, providing ample supply for numerous experiments and investigations.

This antibody is meticulously designed to target CD49D, a key integrin subunit involved in cell adhesion and migration. By specifically binding to CD49D, this antibody enables researchers to gain valuable insights into the intricate mechanisms underlying cellular processes, thereby facilitating breakthrough discoveries and advancements in the field of immunology.

Furthermore, the PE/TR Anti-Human CD49D Antibody [9F10] exhibits exceptional stability and longevity, ensuring its efficacy and performance over an extended period. Its user-friendly nature and straightforward protocol make it accessible to both seasoned researchers and newcomers in the field, promoting ease of use and efficiency in laboratory settings.

In summary, the PE/TR Anti-Human CD49D Antibody [9F10] is a remarkable scientific tool that offers unparalleled precision, reliability, and versatility. With its exceptional performance and user-friendly design, this antibody is poised to revolutionize immunological research and contribute to groundbreaking discoveries in the field.